Biohaven Share Holder Equity 2016-2023 | BHVN
Biohaven share holder equity from 2016 to 2023. Share holder equity can be defined as the sum of preferred and common equity items
Biohaven Annual Share Holder Equity
(Millions of US $) |
| 2022 |
$539 |
| 2021 |
$35 |
| 2020 |
$-392 |
| 2019 |
$-7 |
| 2018 |
$151 |
| 2017 |
$132 |
| 2016 |
$-2 |
| 2015 |
$1 |
Biohaven Quarterly Share Holder Equity
(Millions of US $) |
| 2023-03-31 |
$472 |
| 2022-12-31 |
$539 |
| 2022-09-30 |
$100 |
| 2022-06-30 |
$-806 |
| 2022-03-31 |
$-466 |
| 2021-12-31 |
$35 |
| 2021-09-30 |
$-591 |
| 2021-06-30 |
$-457 |
| 2021-03-31 |
$-278 |
| 2020-12-31 |
$-392 |
| 2020-09-30 |
$-214 |
| 2020-06-30 |
$-35 |
| 2020-03-31 |
$122 |
| 2019-12-31 |
|
| 2019-09-30 |
$119 |
| 2019-06-30 |
$187 |
| 2019-03-31 |
$97 |
| 2018-12-31 |
$151 |
| 2018-09-30 |
$66 |
| 2018-06-30 |
$119 |
| 2018-03-31 |
$108 |
| 2017-12-31 |
$132 |
| 2017-09-30 |
$156 |
| 2017-06-30 |
$193 |
| 2017-03-31 |
$20 |
| 2016-12-31 |
$-2 |
| 2016-09-30 |
$0 |
| 2016-06-30 |
$0 |
| 2016-03-31 |
|
| 2015-12-31 |
$1 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$1.414B |
$0.463B |
|
Biohaven Ltd. is a clinical-stage biopharmaceutical company. It focuses on discovering and developing therapies for patients with debilitating neurological and neuropsychiatric diseases principally in the United States. Biohaven Ltd., formerly known as BIOHAVEN PHARM, is based in New Haven, Connecticut.
|
